abstract |
The present invention relates to a Caudal protein recognizing an E2F promoter, transformants for overexpressing the Caudal protein, and drug screening using the same. Particularly, the Caudal protein overexpressing transformants of the present invention exhibit abnormal proliferation and differentiation, such that they can be used for drug screening. |